IR Information
About Our Company
Our Vision
Management
Corporate Information
Our History
About Our Business
Business Model
R&D Pipelines
News
Policy
Privacy Policy
Anonymously Processing Informations
IR News
IR News
Management Information
IR Library
Other IR Information
FAQ
Japanese
TOP
>
IR News
IR News
2023.12.05
Timely Disclosure
Notice of Allowance of New Use and Dosage Patent for PAI-1 Inhibitor(Title of the Invention: Inhibitor against Expression of Immune Checkpoint Molecule)
(124KB)
2023.10.26
Timely Disclosure
Announcement of Initiation of Phase II Study for Cutaneous Angiosarcoma
(144KB)
2023.10.19
Timely Disclosure
Announcement of Initiation of Phase II study for the treatment of interstitial lung disease associated with systemic scleroderma begins.
(308KB)
2023.10.17
Timely Disclosure
Notice of Allowance of New Use and Dosage Patent for PAI-1 Inhibitor (Title of the Invention: Drug for Enhancing Fibrinolytic System, and Use Thereof)
(135KB)
2023.09.26
Timely Disclosure
Announcement of Initiation of Phase II Study for Non-Small Cell Lung Cancer.
(184KB)
IR News List
Management Information
To Our Shareholders and Investors
Corporate Governance
IR Library
IR Library List
Financial Results
Presentation Materials
General Meeting of Shareholders Materials
Timely Disclosure Information
Other IR Information
Stock Information
IR Calendar
Disclosure Policy
Disclaimer
IR Contact
For IR inquiries, please contact us here.